The new leasing agent for a Norwalk office building has secured a venture-backed biotech company as its newest tenant.

Evolve BioSystems will occupy 10,000 square feet at MerrittView, a 262,500-square-foot office building owned by GLIC Real Estate Holdings. The property at 383 Main Ave. has 85,000 square feet of contiguous availability on two floors spanning 42,000 square feet apiece. Owners are offering pre-built office spaces ranging from 1,000 to 10,232 square feet equipped with furnished workstations, pantries and conference rooms.

Evolve BioSystems has raised $125 million in venture funding to date, including a $65-million series D round in February 2021. The company manufactures a treatment for infant digestive disorders.

Located near the Merritt 7 train station on the Danbury branch of the Metro-North Railroad, MerrittView includes oversized windows with 360-degree views, open floor plans and an internal connecting staircase. Owners are in the midst of a multi-million-dollar capital improvement program including a new cooling tower with hospital-grade MERV 13 air filters, CBRE said.

CBRE’s Tom Pajolek and Ned Burns represent ownership in leasing. Cushman & Wakefield’s Adam Klimek represented Evolve BioSystems in the lease negotiation.